Can a single drug shield kidneys after lung transplant?
NCT ID NCT05950724
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving a TNF-alpha antibody before lung transplant can prevent kidney injury that often happens after surgery. About 20 adults waiting for a lung transplant at Northwestern Memorial Hospital will take part. Researchers will measure kidney function and other outcomes like lung function and hospital stay length.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG TRANSPLANT; COMPLICATIONS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Northwestern University
Chicago, Illinois, 60611, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A smartphone tool may help cystic fibrosis patients survive the lung transplant waitlist
- New drug may protect kidneys in lung transplant patients
- Blood test may let lung transplant patients ditch antiviral drugs sooner
- Massive lung transplant study seeks 2,600 patients to unlock better care
- Lung transplant patients may skip some clinic visits with new app
- Light sensor may predict kidney failure after lung transplant